Go Pro
NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

Intelligent Bio Solutions logo
$1.97 -0.14 (-6.64%)
Closing price 07/20/2026 04:00 PM Eastern
Extended Trading
$2.04 +0.07 (+3.50%)
As of 08:30 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Advanced

Key Stats

Today's Range
$1.90
$2.27
50-Day Range
$1.97
$4.11
52-Week Range
$1.90
$24.90
Volume
303,048 shs
Average Volume
52,270 shs
Market Capitalization
$4.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Intelligent Bio Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

INBS MarketRank™: 

Intelligent Bio Solutions scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Intelligent Bio Solutions has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Intelligent Bio Solutions has only been the subject of 1 research reports in the past 90 days.

  • Read more about Intelligent Bio Solutions' stock forecast and price target.
  • Earnings Growth

    Earnings for Intelligent Bio Solutions are expected to decrease in the coming year, from ($3.42) to ($5.18) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Intelligent Bio Solutions is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Intelligent Bio Solutions is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Intelligent Bio Solutions has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Intelligent Bio Solutions' valuation and earnings.
  • Percentage of Shares Shorted

    3.61% of the float of Intelligent Bio Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Intelligent Bio Solutions has a short interest ratio ("days to cover") of 2.28, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Intelligent Bio Solutions has recently decreased by 19.95%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Intelligent Bio Solutions does not currently pay a dividend.

  • Dividend Growth

    Intelligent Bio Solutions does not have a long track record of dividend growth.

    • Insider Buying vs. Insider Selling

      In the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      1.27% of the stock of Intelligent Bio Solutions is held by insiders.

    • Percentage Held by Institutions

      32.97% of the stock of Intelligent Bio Solutions is held by institutions.

    • Read more about Intelligent Bio Solutions' insider trading history.
    Receive INBS Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

    SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    INBS Stock News Headlines

    INBS Share News Today
    Buy this stock today
    Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel
    See More Headlines

    INBS Stock Analysis - Frequently Asked Questions

    Intelligent Bio Solutions' stock was trading at $9.53 at the start of the year. Since then, INBS shares have decreased by 79.3% and is now trading at $1.97.

    Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced its quarterly earnings results on Wednesday, May, 13th. The company reported ($1.80) earnings per share for the quarter, missing analysts' consensus estimates of $1.40 by $3.20. The business had revenue of $1.06 million for the quarter, compared to analyst estimates of $7.20 million. Intelligent Bio Solutions had a negative net margin of 296.73% and a negative trailing twelve-month return on equity of 176.09%.

    Intelligent Bio Solutions's stock reverse split on the morning of Monday, January 29th 2024.The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

    Intelligent Bio Solutions (INBS) raised $22 million in an initial public offering on Wednesday, December 23rd 2020. The company issued 1,270,589 shares at $16.00-$18.00 per share.

    Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include SoFi Technologies (SOFI), Plug Power (PLUG), Allarity Therapeutics (ALLR), Adial Pharmaceuticals (ADIL), AMC Entertainment (AMC), ARMOUR Residential REIT (ARR) and BIOLASE (BIOL).

    Company Calendar

    Last Earnings
    5/13/2026
    Today
    7/21/2026
    Next Earnings (Estimated)
    8/21/2026
    Fiscal Year End
    6/30/2027

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Medical Services
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:INBS
    Previous Symbol
    NASDAQ:GBS
    CIK
    1725430
    Fax
    N/A
    Employees
    10
    Year Founded
    N/A

    Profitability

    EPS (Trailing Twelve Months)
    ($12.22)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$10.57 million
    Net Margins
    -296.73%
    Pretax Margin
    -297.75%
    Return on Equity
    -176.09%
    Return on Assets
    -89.71%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    2.11
    Quick Ratio
    1.99

    Sales & Book Value

    Annual Sales
    $3.05 million
    Price / Sales
    1.54
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $4.07 per share
    Price / Book
    0.48

    Miscellaneous

    Outstanding Shares
    2,390,000
    Free Float
    2,362,000
    Market Cap
    $4.71 million
    Optionable
    Not Optionable
    Beta
    4.18
    10 Stocks Powering The Next AI Boom  Cover

    The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

    Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

    Get This Free Report

    This page (NASDAQ:INBS) was last updated on 7/21/2026 by MarketBeat.com Staff.
    From Our Partners